Neurofibromatosis type 1 (NF1), a common inherited disorder, causes skin-pigmentation and CNS abnormalities, and increases the risk of developing several types of cancer. It varies widely in clinical presentation, even in family members carrying an identical mutation at the *NF1* locus, suggesting genetic or environmental modifiers. To probe underlying mechanisms, Shin, Padmanabhan et al. studied the zebrafish homologues of human *NF1* -- *nf1a* and *nf1b* -- and used targeted approaches to create *nf1*-null zebrafish, which showed melanophore defects and a range of CNS abnormalities at the larval stage. As hypothesised for human *NF1*, zebrafish *nf1* genes also act as tumour suppressors: *nf1*-null larvae showed hyperactivation of Ras in the spinal cord, and combined loss of *nf1* and *p53* accelerated tumorigenesis. These data indicate that zebrafish *nf1a* and *nf1b* are tumour suppressors with crucial roles in CNS development. This is also the first animal model of NF1 in which pigmentation defects -- an important feature of the human disease -- have been documented. **Page 881**
